EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
119 hedge funds and large institutions have $640M invested in Eagle Pharmaceuticals, Inc. in 2016 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 42 increasing their positions, 36 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
39% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 33
52% less capital invested
Capital invested by funds: $1.32B → $640M (-$682M)
Holders
119
Holding in Top 10
5
Calls
$39.6M
Puts
$15.8M
Top Buyers
| 1 | +$31.7M | |
| 2 | +$17.1M | |
| 3 | +$9.97M | |
| 4 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$8.87M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$8.09M |
Top Sellers
| 1 | -$28.8M | |
| 2 | -$11.8M | |
| 3 | -$6.1M | |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
-$4.31M |
| 5 |
NIP
Nicholas Investment Partners
Rancho Santa Fe,
California
|
-$4.3M |